ALFUZOSIN-TEVA
General data
Product class:
Authorized package
Medicinal product class:
For human use
Package code:
1278198
Name of medicinal product:
ALFUZOSIN-TEVA
Active substances:
Alfuzosin
Estonian
,
English
,
Latin
ATC code:
G04CA01
Dosage form:
prolonged-release tablet
Route of administration:
oral use
Strengh:
10mg
Amount in package:
100TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
Treatment of the functional symptoms of benign prostatic hyperplasia (BPH).
Safety features:
Yes
Summary of product characteristics (SPC):
(last updated 18 April 2023)
Package information leaflet (PIL):
EST
(last updated 18 April 2023)
Labelling:
(last updated 18 April 2023)
Last imported to Estonia:
Never imported to Estonia
Marketing authorization
Marketing authorization holder:
Teva Pharma B.V.
Marketing authorization number:
556507
Marketing authorization issued on:
24 August 2007
Marketing authorization expires on:
Unlimited
Marketing authorization procedure type:
Mutual recognition
Prices
Reference price:
Under reference price:
Reference price of daily dose:
Entry/Changing date: 25 October 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription